SynthesisAJNR. American journal of neuroradiology2022
Pretreatment ADC Histogram Analysis as a Prognostic Imaging Biomarker for Patients with Recurrent Glioblastoma Treated with Bevacizumab: A Systematic Review and Meta-analysis.
Synthesis in AJNR. American journal of neuroradiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Survival prediction using apparent diffusion coefficient values in recurrent glioblastoma under bevacizumab treatment: an updated systematic review and meta-analysisDiagnostic and interventional radiology (Ankara, Turkey) · 2024Pooled it
- Impact of deep learning-based MRI reconstruction on image quality and apparent diffusion coefficient measurements in patients with intracranial tumors: a prospective intra-individual study.Quantitative imaging in medicine and surgery · 2026Article
- Article
- Histogram analysis of continuous-time random walk and restrictive spectrum imaging for identifying hepatocellular carcinoma and intrahepatic cholangiocarcinoma.Frontiers in oncology · 2025Article
- Repeatability quantification of brain diffusion-weighted imaging for future clinical implementation at a low-field MR-linac.Radiation oncology (London, England) · 2024Article
- The value of multiple diffusion metrics based on whole-lesion histogram analysis in evaluating the subtypes and proliferation status of non-small cell lung cancer.Frontiers in oncology · 2024Article
- The value of an apparent diffusion coefficient histogram model in predicting meningioma recurrence.Journal of cancer research and clinical oncology · 2023Article
- Accurate, repeatable, and geometrically precise diffusion-weighted imaging on a 0.35 T magnetic resonance imaging-guided linear accelerator.Physics and imaging in radiation oncology · 2023Article
- Magnetic resonance imaging-derived parameters to predict response to regorafenib in recurrent glioblastoma.Neuroradiology · 2023Article
- Differential diagnosis of atypical and anaplastic meningiomas based on conventional MRI features and ADC histogram parameters using a logistic regression model nomogram.Neurosurgical review · 2023Article
- Comparison of EPI DWI and STEAM DWI in Early Postoperative MRI Controls After Resection of Tumors of the Central Nervous System.Clinical neuroradiology · 2023Article
- Article
- Differential value of diffusion kurtosis imaging and intravoxel incoherent motion in benign and malignant solitary pulmonary lesions.Frontiers in oncology · 2022Article
- Evolution and implementation of radiographic response criteria in neuro-oncology.Neuro-oncology advancesReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe mean ADC value of the lower Gaussian curve (ADC PURPOSE: We applied a systematic review and meta-analysis to investigate the predictive/prognostic performance of ADC DATA SOURCES: We performed a literature search using PubMed, Scopus, and EMBASE. STUDY SELECTION: A total of 1344 abstracts were screened, of which 83 articles were considered potentially relevant. Data were finally extracted from 6 studies including 578 patients. DATA ANALYSIS: Forest plots were generated to illustrate the hazard ratios of overall survival and progression-free survival. The heterogeneity across the studies was assessed using the Cochrane DATA SYNTHESIS: The pooled hazard ratios for overall survival and progression-free survival in patients with an ADC LIMITATIONS: The conclusions are limited by the difference in the definition of recurrence among the included studies.
conclusionsThis systematic review with meta-analysis supports the prognostic value of ADC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.